Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Elizabeth Holdsworth"'
Autor:
Helen Hogan, Andrew Hutchings, Jerome Wulff, Catherine Carver, Elizabeth Holdsworth, Jerry Nolan, John Welch, David Harrison, Nick Black
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Failure to recognise and respond to patient deterioration on hospital wards is a common cause of healthcare-related harm. If patients are not rescued and suffer a cardiac arrest as a result then only around 15% will survive. Track
Externí odkaz:
https://doaj.org/article/5b971d039b7b461fb1452ff3fc11c8f9
Autor:
William Tillett, Joseph F. Merola, Diamant Thaçi, Elizabeth Holdsworth, Nicola Booth, L. Steve Lobosco, Gary Milligan, Matthew M. Hufford, Julie A. Birt, Wolf-Henning Boehncke
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 3, Pp 617-637 (2020)
Abstract Introduction Psoriatic arthritis (PsA) is a chronic, systemic, inflammatory disease where disease burden and quality of life (QoL) are affected by both joint and skin manifestations. Methods Patient and physician reported data were collected
Externí odkaz:
https://doaj.org/article/8bb12b7709b84796ad914cbc83c41c12
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 2, Pp 415-423 (2020)
Abstract Introduction The Food and Drug Administration (FDA) approved certolizumab-pegol, the first biologic for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA), for use in the United States (US) in March of 2019. The objective o
Externí odkaz:
https://doaj.org/article/b6cff6dfbdf34d099ece46ad4a7d1f77
Autor:
Helen Hogan, Andrew Hutchings, Jerome Wulff, Catherine Carver, Elizabeth Holdsworth, John Welch, David Harrison, Nick Black
Publikováno v:
Health Services and Delivery Research, Vol 7, Iss 2 (2019)
Background: Unchecked patient deterioration can lead to in-hospital cardiac arrest (IHCA) and avoidable death. The National Cardiac Arrest Audit (NCAA) has found fourfold variation in IHCA rates and survival between English hospitals. Key to reducing
Externí odkaz:
https://doaj.org/article/5efe78f5bc764a5c93b10fb2042aa558
Publikováno v:
American Journal of Human Biology.
Autor:
Haijun Tian, P.G. Conaghan, Dorothy L. Keininger, Elizabeth Holdsworth, N. Modi, Uta Kiltz, O Howell, Nicola Booth
Publikováno v:
Clinical Rheumatology. 41:471-481
To assess the effectiveness of secukinumab in patients with axSpA treated in routine clinical settings in 5 European countries. Retrospective analysis of a cross-sectional survey to assess real-world effectiveness of secukinumab in the management of
Publikováno v:
Rheumatology and Therapy
Introduction Axial spondyloarthritis (axSpA) is a chronic rheumatic disease affecting the spine and sacroiliac joints, encompassing both ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) patients. Patient quality of
Publikováno v:
Clinical Rheumatology
Objectives The aim of this study was to compare the symptoms, treatment patterns, and quality of life (QoL) of ankylosing spondylitis (AS) patients to non-radiographic axial spondyloarthritis (nr-axSpA) patients in the USA. Method A cross-sectional s
Autor:
Laure Gossec, Jessica A. Walsh, Kaleb Michaud, Elizabeth Holdsworth, Steve Peterson, Sophie Meakin, Feifei Yang, Nicola Booth, Soumya D. Chakravarty, James Piercy, Natalie Dennis, Alexis Ogdie
Publikováno v:
Journal of Rheumatology
Journal of Rheumatology, 2022, 49 (11), pp.1221-1228. ⟨10.3899/jrheum.211288⟩
Journal of Rheumatology, 2022, 49 (11), pp.1221-1228. ⟨10.3899/jrheum.211288⟩
Objective To evaluate fatigue frequency and severity among patients with psoriatic arthritis (PsA) and assess the effect of fatigue severity on patient-reported outcome measures (PROMs) assessing quality of life, function, and work productivity. Meth
Autor:
Elizabeth Holdsworth, Ana Maria Orbai, Anthony M. Reginato, Julie Birt, Nicola Booth, William N Malatestinic, Aubrey Trevelin Sprabery
Publikováno v:
Rheumatology and Therapy
Rheumatology and Therapy, Vol 7, Iss 4, Pp 937-948 (2020)
Rheumatology and Therapy, Vol 7, Iss 4, Pp 937-948 (2020)
Introduction Enthesitis is a core outcome domain assessed in psoriatic arthritis (PsA) clinical trials. Limited evidence describes the impact of enthesitis on patient-reported outcomes (PROs) and physician satisfaction with current treatment options.